reports
- GlobalData Healthcare Department
PharmaEssentia Corp (6446) - Financial Analysis Review
PharmaEssentia Corp (6446) - Financial Analysis Review Summary PharmaEssentia Corp (PharmaEssentia) is a research and development company that develops therapeutic products for the treatment of human diseases. The company’s pipeline product include P1101, a new generation PEG-Interferon-alpha-2b which is developed using PEGylation technology platform. Its pegylation technology platform is designed to increase the protein drug's efficacy by prolonging its circulation in the bloodstreamd. Glo...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.